What is Osteoporosis Holistic Quadruple Therapy?

  Osteoporosis is a disease in which the amount of bone per unit volume decreases, the microstructure of bone tissue deteriorates, and the brittleness of bone increases, making it easy to cause fractures.
  Diagnosis: Osteoporosis can be diagnosed in women after menopause and men after 65 years of age, or in those who are bedridden for a long time due to other diseases, with generalized bone pain, back pain, weakness of limbs, fragility fracture (fracture caused by slight force or movement), vertebral compression fracture, hunchback, shortening of height, and bone density value less than or equal to 2.5 standard deviations on dual-energy X-ray bone density examination.
  With the Chinese Medical Association issued as a guide, comprehensive years of clinical experience in treating the disease, the overall quadruple therapy for osteoporosis is proposed, with satisfactory results, and most patients can significantly improve symptoms such as low back pain in 4.5 days of treatment.
  I. Diet.
  Eat foods rich in calcium, such as soy products, dairy products, aquatic products, etc., to supplement the body’s insufficient calcium.
  Second, exercise.
  Outdoor activities, receiving sunlight, generating vitamin D, which is conducive to the absorption of calcium and conversion into bone tissue. Light jumping and jogging, produce piezoelectric effect, conducive to bone growth.
  Third, drugs.
  1, promote bone mineralization class of drugs: a variety of calcium and vitamin D3, such as calcium, LELI and other calcium complex, can be supplemented with calcium and vitamin D3 at the same time.
  2, inhibit bone resorption drugs.
  (1) Intramuscular injection of salmon calcitonin (10 micrograms/injection), one injection per day in the first week, two injections per week in the second to fifth weeks, and one injection per week in the sixth to tenth weeks, for a total of 20 injections.
  Calcitonin is a peptide hormone secreted by parafollicular cells in the thyroid and parathyroid glands, and has the effect of inhibiting osteoclast activity. It can inhibit bone salt dissolution and prevent calcium release from bone, which can produce a lowering effect on blood calcium because the uptake of calcium by bone is still going on.
  Salmon calcitonin has the highest activity in animals. Salmon calcitonin is a powerful anti-osteolysis and promotes the production of osteoblasts. It can lower blood calcium, prevent calcium ions from entering nerve cell membranes, lower intracellular calcium ion levels, regulate the sensitivity of pain receptors, and thus increase the threshold of pain tolerance.
  (2) Postmenopausal women can take estrogen and progestin. For example, Neil estrogenized tablets (Venian tablets 1mg*6) can be maintained for 20~25 days with 1mg taken orally; Geflun is taken once a day, 2 capsules each time, 1 hour after meal, 21 days as a course of treatment, and the drug should be stopped for 1 week between courses.
  Osteoporosis in postmenopausal women is related to endogenous estrogen. The decrease of estrogen, the inhibition of osteoclasts is weakened, osteoclasts are relatively strengthened, and there is an obvious imbalance between osteoclasts and osteogenesis, resulting in increased bone resorption and reduced bone formation, leading to gradual bone loss.
  (3) Diphosphonates: bone phosphorus 400mg/d, disodium chloromethylbisphosphate, sodium hydroxyethyl diphosphate, alendronate sodium, etc. Can inhibit bone resorption, reduce bone loss, and has a pain-relieving effect
  3, to promote bone formation drugs: sodium fluoride daily oral 1mg/kg, divided into 36 times, must be added at the same time with calcium. Fluorosis can occur in overdose, and there is no more fracture in 90% of cases after 18 months of application.
  4. Chinese medicine: nourish the liver and kidney, strengthen the tendons and bones, such as the Chinese medicine Xian Ling Bone Depot capsule.
  IV. Physical therapy.
  Osteoporosis treatment instrument can generate specific low-frequency pulse electromagnetic field, acting on the human skeletal system, excite osteoblasts and inhibit osteoclasts, so that bone metabolism to the direction conducive to bone growth and accelerate the growth of bone tissue.
  In the past, the simple application of drugs to treat osteoporosis can only slow down the rate of bone loss and cannot increase bone density, while the application of this treatment program can not only reduce bone loss, but also increase bone mass by 5%-8% and greatly reduce the risk of fracture, which is a gospel for the majority of osteoporosis patients.